Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

23 Citations (Scopus)

Abstract

The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.
Original languageEnglish
Pages (from-to)695-697
Number of pages3
JournalJournal of Medical Virology
Volume93
Issue number2
Early online date9 Sep 2020
DOIs
Publication statusPublished - 1 Feb 2021

Fingerprint

Dive into the research topics of 'Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis'. Together they form a unique fingerprint.

Cite this